Novartis Gets Phase 3-Ready Rare Kidney Disease Drug via $800M Regulus Acquisition
Novartis has made kidney disorders an area of focus, and it’s now adding a new drug prospect through a deal ...
Novartis has made kidney disorders an area of focus, and it’s now adding a new drug prospect through a deal ...
"It is a very-very good liquidity provision they have done. Now, followed up with another repo rate cut and changing ...
Sir Keir Starmer has declared that plans to put a peacekeeping force in Ukraine have now entered an “operational phase”, ...
US President Donald Trump’s Middle East envoy-designate Steve Witkoff gives a speech at the inaugural parade inside Capital One Arena ...
There are victories that reveal clues that should not be overlooked and last night Inter returned to Milan with many ...
Ukraine’s surprise offensive into Russia last month has shaken up the war in Ukraine -- the operation igniting a volatile ...
An Ionis Pharmaceuticals drug in development for Angelman syndrome has mid-stage clinical trial results showing improvement across a range of ...
Rapport Therapeutics, a young biotech company with technology from the labs of Johnson & Johnson, is now preparing to enter ...
G7 energy and climate ministers agreed a time frame Tuesday for phasing out coal-fired power plants that are not equipped ...
Elon Musk’s Tesla is off to a difficult start in 2024, and it’s probably no surprise to Akio Toyoda. The ...
Copyright © 2024 EuroAsia24 News.
EuroAsia24 News is not responsible for the content of external sites.